PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting

NCT03204279 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Chemotherapy-induced Nausea and Vomiting (CINV)

Interventions

DRUG: Netupitant
DRUG: Palonosetron
DRUG: Netupitant
DRUG: Palonosetron

Sponsor

Helsinn Healthcare SA